By profiling gene expression in colon cancer cell clones, researchers identified signatures linked to metastatic risk and ...
Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...
UNIGE scientists developed an algorithm able to anticipate the risk of cancer metastasis and recurrence. Group of human colon ...
Published on UNIGE scientists developed an algorithm able to anticipate the risk of cancer metastasis and recurrence. Group of human colon ...
This article explores how advances in data, genomics and artificial intelligence are improving our ability to estimate ...
Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in patients with high-risk resected melanoma over 5 years. The personalized mRNA therapy targets ...
Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the ...
Johns Hopkins biomedical engineers Ishan Vatsaraj, Stanley Chun Ming Wu, and Jaemyung Shin have been awarded highly ...
Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developersCHICAGO, Jan. 15, 2026 /PRNewswire/ -- A new consensus document ...
A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO ...
Controversy surrounding the artificial intelligence (AI) chatbot ‘Grok,’ operated by Tesla CEO Elon Musk, continues to ...
YD Bio Limited ('YD Bio” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that the ...